Barton VN - Search Results

1

Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.

Barton VN, D'Amato NC, Gordon MA, Christenson JL, Elias A, Richer JK. Barton VN, et al. Horm Cancer. 2015 Dec;6(5-6):206-13. doi: 10.1007/s12672-015-0232-3. Epub 2015 Jul 23. Horm Cancer. 2015. PMID: 26201402 Free PMC article. Review.

2

Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo.

Barton VN, D'Amato NC, Gordon MA, Lind HT, Spoelstra NS, Babbs BL, Heinz RE, Elias A, Jedlicka P, Jacobsen BM, Richer JK. Barton VN, et al. Mol Cancer Ther. 2015 Mar;14(3):769-78. doi: 10.1158/1535-7163.MCT-14-0926. Epub 2015 Feb 23. Mol Cancer Ther. 2015. PMID: 25713333 Free PMC article.

3

Anti-androgen therapy in triple-negative breast cancer.

Barton VN, Gordon MA, Richer JK, Elias A. Barton VN, et al. Ther Adv Med Oncol. 2016 Jul;8(4):305-8. doi: 10.1177/1758834016646735. Epub 2016 May 31. Ther Adv Med Oncol. 2016. PMID: 27482289 Free PMC article. No abstract available.

4

Cooperative Dynamics of AR and ER Activity in Breast Cancer.

D'Amato NC, Gordon MA, Babbs B, Spoelstra NS, Carson Butterfield KT, Torkko KC, Phan VT, Barton VN, Rogers TJ, Sartorius CA, Elias A, Gertz J, Jacobsen BM, Richer JK. D'Amato NC, et al. Among authors: barton vn. Mol Cancer Res. 2016 Nov;14(11):1054-1067. doi: 10.1158/1541-7786.MCR-16-0167. Epub 2016 Aug 26. Mol Cancer Res. 2016. PMID: 27565181 Free PMC article.

5

Androgen Receptor Supports an Anchorage-Independent, Cancer Stem Cell-like Population in Triple-Negative Breast Cancer.

Barton VN, Christenson JL, Gordon MA, Greene LI, Rogers TJ, Butterfield K, Babbs B, Spoelstra NS, D'Amato NC, Elias A, Richer JK. Barton VN, et al. Cancer Res. 2017 Jul 1;77(13):3455-3466. doi: 10.1158/0008-5472.CAN-16-3240. Epub 2017 May 16. Cancer Res. 2017. PMID: 28512248 Free PMC article.

6

Aurora kinase A as a rational target for therapy in glioblastoma.

Barton VN, Foreman NK, Donson AM, Birks DK, Handler MH, Vibhakar R. Barton VN, et al. J Neurosurg Pediatr. 2010 Jul;6(1):98-105. doi: 10.3171/2010.3.PEDS10120. J Neurosurg Pediatr. 2010. PMID: 20593995

7

Survey of MicroRNA expression in pediatric brain tumors.

Birks DK, Barton VN, Donson AM, Handler MH, Vibhakar R, Foreman NK. Birks DK, et al. Among authors: barton vn. Pediatr Blood Cancer. 2011 Feb;56(2):211-6. doi: 10.1002/pbc.22723. Epub 2010 Nov 3. Pediatr Blood Cancer. 2011. PMID: 21157891

8

Insulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytoma.

Barton VN, Donson AM, Birks DK, Kleinschmidt-DeMasters BK, Handler MH, Foreman NK, Rush SZ. Barton VN, et al. J Neuropathol Exp Neurol. 2013 May;72(5):442-9. doi: 10.1097/NEN.0b013e31829023dd. J Neuropathol Exp Neurol. 2013. PMID: 23584203 Free PMC article.

9

PARP1 expression in pediatric central nervous system tumors.

Barton VN, Donson AM, Kleinschmidt-DeMasters BK, Gore L, Liu AK, Foreman NK. Barton VN, et al. Pediatr Blood Cancer. 2009 Dec 15;53(7):1227-30. doi: 10.1002/pbc.22141. Pediatr Blood Cancer. 2009. PMID: 19533660

10

Immune gene and cell enrichment is associated with a good prognosis in ependymoma.

Donson AM, Birks DK, Barton VN, Wei Q, Kleinschmidt-Demasters BK, Handler MH, Waziri AE, Wang M, Foreman NK. Donson AM, et al. Among authors: barton vn. J Immunol. 2009 Dec 1;183(11):7428-40. doi: 10.4049/jimmunol.0902811. Epub 2009 Nov 16. J Immunol. 2009. PMID: 19917695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page